Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.
- DOI
- 10.1002/art.42948
- Published
- 2024 Nov
- Container
- Arthritis & rheumatology (Hoboken, N.J.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/art.42948,
title = {Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.},
author = {Yang Z and Tao P and Han X and Kozlova A and He T and Volchkov E and Nesterenko Z and Pershin D and Raykina E and Fatkhudinov T and Korobeynikova A and Aksentijevich I and Yang J and Shcherbina A and Zhou Q and Yu X},
year = {2024},
journal = {Arthritis \& rheumatology (Hoboken, N.J.)},
doi = {10.1002/art.42948},
url = {https://doi.org/10.1002/art.42948}
}RIS
TY - JOUR TI - Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor. AU - Yang Z AU - Tao P AU - Han X AU - Kozlova A AU - He T AU - Volchkov E AU - Nesterenko Z AU - Pershin D AU - Raykina E AU - Fatkhudinov T AU - Korobeynikova A AU - Aksentijevich I AU - Yang J AU - Shcherbina A AU - Zhou Q AU - Yu X PY - 2024 JO - Arthritis & rheumatology (Hoboken, N.J.) DO - 10.1002/art.42948 UR - https://doi.org/10.1002/art.42948 ER -
APA
Z, Y., P, T., X, H., A, K., T, H., E, V., Z, N., D, P., E, R., T, F., A, K., I, A., J, Y., A, S., Q, Z., & X, Y. (2024). Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.. Arthritis & rheumatology (Hoboken, N.J.). https://doi.org/10.1002/art.42948
Source records
- pubmed · retrieved 2026-09-26T08:27:57.267Z